Home/ Stocks/ PULM

Pulmatrix, Inc. Common Stock

PULM XNAS

$2.15 -0.11 (-4.87%) ▼ 15-min delayed

Open

$2.28

High

$2.28

Low

$2.11

Volume

12.0K

Market Cap

$8.25M

About Pulmatrix, Inc. Common Stock

Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Sector: PHARMACEUTICAL PREPARATIONS Employees: 2 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$0	$-5,162,000	$-1.41
FY 2025	$0	$-5,162,000	$-1.41
Q3 2025	$0	$-877,000	$-0.24
Q2 2025	$0	$-1,549,000	$-0.42

Earnings & Analyst Ratings

Next Earnings: Wed, May 13, 2026

Calendar →

Related Market News

No specific coverage for PULM yet. Check out our latest market news or earnings calendar.

Get PULM Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Pulmatrix, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.